Literature DB >> 24447390

The origin of Behçet's disease geoepidemiology: possible role of a dual microbial-driven genetic selection.

Matteo Piga1, Alessandro Mathieu.   

Abstract

It is recognised that the genetic profiles that give rise to chronic inflammatory diseases, under the influence of environmental agents, might have been implicated in the host defence mechanism against lethal infections in the past. Behçet's disease (BD) is an immune-mediated inflammatory disease, expressed as vasculitis, triggered by environmental factors in genetically susceptible individuals. We carried out a review of published data to draw up an evolutionary adaptation model, as Author's perspective, for genetic susceptibility factors and inflammatory immune response involved in BD pathogenesis. Two lethal infectious agents, Plasmodium Falciparum and Yersinia Pestis, are proposed as the putative driving forces that favoured the fixing of the major genetic susceptibility factors to BD, thus determining its geoepidemiology. Further studies are needed to confirm the validity of this evolutionary model which includes and integrates the key insights of previous hypotheses.

Entities:  

Mesh:

Year:  2014        PMID: 24447390

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Genetic origin of Behçet's disease population in Denizli, Turkey; population genetics data analysis; historical demography and geographical perspectives based on β-globin gene cluster haplotype variation.

Authors:  O Ozturk; S Arikan; A Bahadir; A Atalay; E O Atalay
Journal:  Genes Immun       Date:  2016-12-29       Impact factor: 2.676

2.  Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome.

Authors:  Alberto Floris; Matteo Piga; Silvia Pinna; Maria Maddalena Angioni; Mattia Congia; Piero Mascia; Elisabetta Chessa; Ignazio Cangemi; Alessandro Mathieu; Alberto Cauli
Journal:  Open Access Rheumatol       Date:  2019-10-08

3.  The association analysis between HLA-A*26 and Behçet's disease.

Authors:  Jutaro Nakamura; Akira Meguro; Genji Ishii; Takahiro Mihara; Masaki Takeuchi; Yuki Mizuki; Kentaro Yuda; Takahiro Yamane; Tatsukata Kawagoe; Masao Ota; Nobuhisa Mizuki
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

4.  Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI).

Authors:  Matteo Piga; Alberto Floris; Gerard Espinosa; Luísa Serpa Pinto; Nikolaos Kougkas; Andrea Lo Monaco; Giuseppe Lopalco; Ida Orlando; Vittorio Pirani; Ernestina Santos; George Bertsias; Luca Cantarini; Alberto Cauli; Ricard Cervera; João Correia; Marcello Govoni; Florenzo Iannone; Piergiorgio Neri; Ana Martins Silva; Carlos Vasconcelos; Monica Muntoni; Alessandro Mathieu
Journal:  RMD Open       Date:  2020-07

5.  Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohort.

Authors:  Alberto Floris; Gerard Espinosa; Luisa Serpa Pinto; Nikolaos Kougkas; Andrea Lo Monaco; Giuseppe Lopalco; Ida Orlando; George Bertsias; Luca Cantarini; Ricard Cervera; João Correia; Marcello Govoni; Florenzo Iannone; Alessandro Mathieu; Piergiorgio Neri; Ana Martins Silva; Carlos Vasconcelos; Monica Muntoni; Alberto Cauli; Matteo Piga
Journal:  Arthritis Res Ther       Date:  2020-11-25       Impact factor: 5.156

6.  Diverse selection pressures shaping the genetic architecture of behçet disease susceptibility.

Authors:  Efe Sezgin; Elif Kaplan
Journal:  Front Genet       Date:  2022-09-30       Impact factor: 4.772

7.  AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population.

Authors:  Maria Maddalena Angioni; Matteo Piga; Fabiana Paladini; Sara Lai; Gian Luca Erre; Alberto Floris; Alberto Cauli; Maria Teresa Fiorillo; Giuseppe Passiu; Carlo Carcassi; Rosa Sorrentino; Alessandro Mathieu
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.